Small dense low density lipoprotein predominance in patients with type 2 diabetes mellitus using Mendelian randomization
Open Access
- 8 February 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (2) , e0298070
Abstract
Background: Patients with T2DM often suffer from CVD-related complications, significantly impacting morbidity and mortality rates. The upsurge in CVD prevalence among them is partly linked to sd LDL particles. Understanding the mechanisms behind elevated sd LDL levels is critical for preventing and managing cardiovascular complications in diabetes. Methods: MR was employed to identify instrumental variables and establish causality, exploring underlying mechanisms. Results: Notably, T2DM itself, insulin resistance, and fasting glucose seemingly do not directly impact sd LDL levels. Instead, the presence of T2DM or insulin resistance, leading to reduced HDL cholesterol or elevated TG levels, directly contributes to subsequent sd LDL increases, indicating a comprehensive mediating effect. While LDL cholesterol levels correlate positively with sd LDL, they appear unaffected by T2DM or insulin resistance. Importantly, hypertension induced by T2DM or insulin resistance exhibits a positive effect on sd LDL reversal. Unlike T2DM or insulin resistance, blood glucose levels show no significant impact on all processes. Conclusions: It is hoped that these insights might influence the treatment of patients with diabetes and the management of blood parameters in clinical practice. Examining the effect of T2DM or insulin resistance on sd LDL within HDL cholesterol and triglycerides pathways might provide valuable insights for targeted cardiovascular treatments. Additionally, the study’s exploration of the potential positive effects of elevated blood pressure on sd LDL reversal may introduce novel considerations for blood pressure management in patients with diabetes.Keywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2020MH361)
- China Postdoctoral Science Foundation (2021M692750)
This publication has 34 references indexed in Scilit:
- Small dense LDL: An emerging risk factor for cardiovascular diseaseClinica Chimica Acta, 2012
- Prediabetic Obese Adolescents have a More Atherogenic Lipoprotein Profile Compared with Normoglycemic Obese PeersThe Journal of Pediatrics, 2012
- Small Dense LDL Cholesterol and Coronary Heart Disease: Results from the Framingham Offspring StudyClinical Chemistry, 2010
- Australian Aboriginal people and Torres Strait Islanders have an atherogenic lipid profile that is characterised by low HDL-cholesterol level and small LDL particlesAtherosclerosis, 2008
- Clinical importance and therapeutic modulation of small dense low-density lipoprotein particlesExpert Opinion on Biological Therapy, 2006
- Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in WomenCirculation, 2002
- Dyslipidaemia in patients with malignant-phase hypertensionQJM: An International Journal of Medicine, 2001
- Relationship of LDL Size to Insulin Sensitivity in Normoglycemic MenArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring studyMetabolism, 1996
- Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes.Circulation, 1993